Table 1.
Order | Sites | Total no. of cases | Percent |
---|---|---|---|
1 | Breast | 2798 | 49.75% |
2 | Cervix uteri | 412 | 7.33% |
3 | Ovary | 355 | 6.31% |
4 | Other skin | 152 | 2.70% |
5 | Connective and soft tissue | 151 | 2.68% |
6 | Non-Hodgkin lymphoma | 125 | 2.22% |
7 | Liver | 118 | 2.10% |
8 | Kaposi sarcoma | 98 | 1.74% |
9 | Bone | 97 | 1.72% |
10 | Corpus uteri | 90 | 1.60% |
11 | Uterus unspecified | 92 | 1.64% |
12 | Rectum | 85 | 1.51% |
13 | Colon | 75 | 1.33% |
14 | Thyroid | 65 | 1.16% |
15 | Nasopharynx | 60 | 1.07% |
16 | Hodgkin disease | 59 | 1.05% |
17 | Eye | 52 | 0.92% |
18 | Kidney | 43 | 0.76% |
19 | Nose, sinuses, etc. | 43 | 0.76% |
20 | Myeloid leukemia | 42 | 0.75% |
21 | Other female genital organs | 38 | 0.68% |
22 | Vulva | 37 | 0.66% |
23 | Anus | 37 | 0.66% |
24 | Salivary glands | 34 | 0.60% |
25 | Placenta | 32 | 0.57% |
26 | Brain, nervous system | 28 | 0.50% |
27 | Stomach | 27 | 0.48% |
28 | Vagina | 25 | 0.44% |
29 | Mouth | 19 | 0.34% |
30 | Bladder | 18 | 0.32% |
31 | Pancreas | 18 | 0.32% |
32 | Trachea, bronchus, and lung | 17 | 0.30% |
33 | Melanoma of skin | 12 | 0.21% |
34 | Hypopharynx | 11 | 0.20% |
35 | Tongue | 10 | 0.18% |
36 | Esophagus | 10 | 0.18% |
37 | Lymphoid leukemia | 10 | 0.18% |
38 | Myeloproliferative disorders | 10 | 0.18% |
39 | Leukemia unspecified | 9 | 0.16% |
40 | Other thoracic organs | 8 | 0.14% |
41 | Lip | 7 | 0.12% |
42 | Pharynx unspecified | 6 | 0.11% |
43 | Multiple myeloma | 5 | 0.09% |
44 | Adrenal gland | 4 | 0.07% |
45 | Other endocrine | 4 | 0.07% |
46 | Small intestine | 4 | 0.07% |
47 | Gallbladder, etc. | 4 | 0.07% |
48 | Tonsil | 4 | 0.07% |
49 | Larynx | 2 | 0.04% |
50 | Mesothelioma | 2 | 0.04% |
51 | Renal pelvis | 2 | 0.04% |
52 | Other oropharynx | 2 | 0.04% |
53 | Immunoproliferative diseases | 1 | 0.02% |
Total | 5624 | 100 |